跳至主要内容
临床试验/NCT00776906
NCT00776906已完成不适用

Advance® 18PTX® Balloon Catheter Study: Treatment of Lesions in Superficial Femoral Artery/Popliteal Artery With a Paclitaxel-coated Balloon

Cook Group Incorporated4 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2008年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
4
主要终点
Evaluation of Late Lumen Loss

研究概览

简要总结

The Advance® 18 PTX® Balloon Catheter study is a clinical trial to study the safety and effectiveness of the Advance 18® PTX® Balloon Catheter in the treatment of lesions in the superficial femoral artery and popliteal artery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age >18 years.
  • •Able to provide informed consent.
  • •Has at least one de novo or restenotic lesion(s) with > 70% stenosis documented angiographically of the SFA or popliteal artery. If more than one lesion requires intervention, only one should be treated as a study lesion.

排除标准

  • •Has significant stenosis (> 50%) or occlusion of inflow tract (proximal ipsilateral, iliofemoral, or aortic lesions) not successfully treated before this procedure.
  • •Lack of at least one patent runoff vessel with < 50% stenosis throughout its course.
  • •Lesions in target area requiring atherectomy (or ablative devices), cutting balloons, cryoplasty balloons, or any other advanced device to facilitate angioplasty balloon or stent delivery.

研究组 & 干预措施

1

Experimental

PTX-coated balloon

干预措施: Advance® 18PTX® Balloon Catheter (Device)

2

Active Comparator

Bare balloon

干预措施: Advance® 18LP Balloon Catheter (Device)

结局指标

主要结局

Evaluation of Late Lumen Loss

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Advance® 18PTX® Balloon Catheter Study | 临床试验